Foundayo vs Wegovy Pill
The Two Oral GLP-1 Weight Loss Pills — Complete Comparison (2026)
For the first time, there are two FDA-approved oral GLP-1 weight loss pills. Foundayo (orforglipron) is Eli Lilly's non-peptide pill you can take any time, with or without food. The Wegovy pill (oral semaglutide 25 mg) is Novo Nordisk's peptide pill that requires an empty stomach and a 30-minute wait. Here's how they compare.
Foundayo vs Wegovy Pill: At a Glance
- ✓Non-peptide small-molecule GLP-1 pill
- ✓Once daily — any time, with or without food
- ✓No fasting, no water restrictions, no timing rules
- ✓Phase 2: ~14.7% body weight loss; ATTAIN-1: up to 27.3 lbs
- ✓Stable at room temperature
- ✓Eli Lilly — FDA approved April 2026
- ✓Peptide GLP-1 (semaglutide) with SNAC absorption enhancer
- ✓Once daily on an empty stomach
- ✓Requires 30-minute wait before food, drink, or other meds
- ✓~13–15% body weight loss in the OASIS program
- ✓First oral GLP-1 approved for weight loss
- ✓Novo Nordisk — FDA approved, launched early 2026
Detailed Comparison
| Feature | Foundayo (Orforglipron) | Wegovy Pill (Oral Semaglutide) |
|---|---|---|
| Brand | Foundayo | Wegovy (oral)Best |
| Generic | Orforglipron (LY3502970) | Semaglutide 25 mg |
| Manufacturer | Eli Lilly | Novo Nordisk |
| Drug Type | Non-peptide small molecule | Peptide + SNAC enhancer |
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Administration | Once-daily pill | Once-daily pill |
| Fasting Required | No — any time, with food | Yes — empty stomach + 30-min wait |
| Water Restriction | None | Small sip only; wait 30 min |
| Key Weight Loss | Phase 2 ~14.7%; ATTAIN-1 up to 27.3 lbs | OASIS program ~13–15% |
| Storage | Room temperature | Room temperature |
| Side Effects | Nausea, vomiting, diarrhea (dose-dependent) | Nausea, vomiting, diarrhea, constipation |
| FDA Status | Approved April 2026 | Approved / launched early 2026 |
Choose Based on Your Priorities
Hate Fasting Rules
Foundayo wins decisively. No empty stomach, no 30-minute wait, no timing around coffee or other pills. Take it whenever — adherence is far easier.
Proven Molecule
The Wegovy pill is semaglutide — the most studied GLP-1 in the world, with years of injectable real-world data behind the same active drug.
Real-World Adherence
The Wegovy pill's fasting protocol is the main reason people miss or mistime doses (the same issue Rybelsus has). Foundayo removes that failure point entirely.
Weight-Loss Ceiling
Both land in a similar ~13–15% range in trials. Foundayo's ATTAIN-1 showed up to 27.3 lbs at higher doses. Neither matches top injectables yet.
No Needles
Both are pills — either one frees you from injections, sharps disposal, and injection-site rotation. This is the shared advantage over Wegovy HD or Zepbound.
Cost & Access
Foundayo self-pay starts around $149/mo for the lowest dose. Wegovy pill pricing tracks Novo's obesity portfolio. Check savings cards and insurance for both.
Which Oral Pill Should You Choose?
Both Foundayo and the Wegovy pill solve the biggest objection to GLP-1 therapy — needles. The deciding factor between them is almost always the fasting protocol. The Wegovy pill, like Rybelsus, is a peptide that only absorbs reliably on an empty stomach, so you take it with a small sip of water and wait 30 minutes before anything else. Foundayo is a non-peptide that survives digestion on its own, so there are no timing rules at all.
If you are disciplined about a consistent morning routine, the Wegovy pill gives you semaglutide — the most clinically proven GLP-1 molecule. If you travel, have an irregular schedule, or already struggle with Rybelsus's fasting window, Foundayo's "any time, with food" simplicity is likely to mean better real-world adherence and therefore better results.
Efficacy in trials is broadly comparable (roughly 13–15%), so for many people this choice comes down to lifestyle fit rather than raw potency. Whichever you start, track your dose timing, appetite, and weight in Shotlee so you can tell whether the protocol is actually working for you.
Foundayo vs Wegovy Pill: Frequently Asked Questions
Both are once-daily oral GLP-1 weight loss pills. Foundayo (orforglipron) is a non-peptide you can take any time with or without food. The Wegovy pill (oral semaglutide 25 mg) is a peptide that must be taken on an empty stomach with a 30-minute wait before eating.
They are broadly comparable in trials — roughly 13–15% body weight loss. Foundayo's ATTAIN-1 showed up to 27.3 lbs at higher doses. There is no direct head-to-head trial yet, so cross-trial comparisons are only directional.
Yes. The Wegovy pill uses the same SNAC absorption technology as Rybelsus, so it must be taken on an empty stomach with a small sip of water, waiting 30 minutes before food, drink, or other medications. Foundayo has no such requirement.
No. Foundayo is orforglipron (a non-peptide small molecule from Eli Lilly). The Wegovy pill is oral semaglutide (a peptide from Novo Nordisk). They are different drugs that happen to share the oral, once-daily format.
Yes. Shotlee tracks any GLP-1 medication, including both oral pills — dose, timing, side effects, and weight. You can compare your results across protocols if you switch.
Track Foundayo or the Wegovy Pill in Shotlee
Free dose timing, side-effect logging, and weight trends for any oral GLP-1 protocol.